Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Thiotepa
Burkitt Lymphoma
Fifth Affiliated Hospital, Sun Yat-Sen University
P2
B
(61)
Thiotepa
Hemoglobinopathy
University of California, San Francisco
P2
B
(61)
Thiotepa
Hodgkins Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(61)
Thiotepa
Sickle Cell Disease
St. Jude Children's Research Hospital
P2
B
(61)
Tislelizumab
Extranodal Nasal NK/T Cell Lymphoma
Rong Tao
P2
B
(61)
Tisotumab Vedotin
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P2
B
(61)
Trametinib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
B
(61)
Trastuzumab
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P2
B
(61)
Trastuzumab Emtansine
Non-Small Cell Lung Carcinoma
Guangzhou Institute of Respiratory Disease
P2
B
(61)
Tucidinostat
Non-Small Cell Lung Carcinoma
Guangdong Association of Clinical Trials
P2
B
(61)
Veliparib
Anaplastic Astrocytoma
National Cancer Institute (NCI)
P2
B
(61)
Venetoclax
Waldenstrom Macroglobulinemia
AbbVie
P2
B
(61)
Vincristine Sulfate
Acute Leukemia Of Ambiguous Lineage
Children's Oncology Group
P2
B
(61)
Vincristine Sulfate
B-Cell Non-Hodgkin Lymphoma
David Bond, MD
P2
B
(61)
Vinorelbine Ditartrate
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug Research
P2
B
(61)
Vitamin D
Hypertensive Disorder
Agricultural University of Athens
P2
B
(61)
Xaliplatin
Angioimmunoblastic T-Cell Lymphoma
Arvinas Inc.
P2
B
(61)
Xaliplatin
B-Cell Non-Hodgkin Lymphoma
Mwanasha Merrill, MD
P2
B
(61)
Xaliplatin
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.
P2
B
(61)
Xaliplatin
Gallbladder Carcinoma
Lisata Therapeutics, Inc.
P2
B
(61)
Xaliplatin
Melanoma
Pfizer
P2
B
(61)
Xaliplatin
Renal Cell Carcinoma
Arcus Biosciences, Inc.
P2
B
(61)
Xaliplatin
Nodal Marginal Zone B-Cell Lymphoma
Izidore Lossos, MD
P2
B
(61)
Xaliplatin
Prostate Cancer
Parabilis Medicines, Inc.
P2
B
(61)
zt002
Obesity Disorder
Beijing QL Biopharmaceutical Co.,Ltd
P2
B
(61)
Showing 1501 to 1525 of 13,155 assets
Previous
Page 61 of 527
Next